Researchers are usually bright people, but funding is often decided by entirely different people, and policy. But anyway ... Vaccines, as well as antibiotics a

Researchers are usually bright people, but funding is often decided by entirely different people, and policy. But anyway ... Vaccines, as well as antibiotics are hard to find/make and eithee have high price sensitivity, nobody will pay a million for a dose of vaccine, or as with new antibiotics, will only be used as a last resort to combat bacterial resistance. As most medical research today is made by for profit companies, less money is spent on things that are harder to make money on. Many 'easy' vaccines are already done, and the same goes for antibiotics, so there is. need to move public funding into the entire pipeline for these kinds of substances. Almost forgot, antivenoms also suffer from this, mostly because there are many venoms, and few victims.